Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02884791 · ClinicalTrials.gov registry record · NA
FGF21 and Fructose Challenge in Humans
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02884791 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 50 participants.
The verdict
NCT02884791, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The primary aim of this study is to examine the effect of acute ingestion of fructose on serum FGF21 levels. Subjects in this study will be lean volunteers and individuals with metabolic syndrome.
Interventions
- DIETARY_SUPPLEMENT oral carbohydrate challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-02 |
| Est. Completion | 2023-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02884791
The ClinicalTrials.gov registry entry for NCT02884791 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which oral carbohydrate challenge is the first listed.
NCT02884791 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02884791 about?
NCT02884791 is a clinical study titled "FGF21 and Fructose Challenge in Humans". The primary aim of this study is to examine the effect of acute ingestion of fructose on serum FGF21 levels. Subjects in this study will be lean volunteers and individuals with metabolic syndrome.
What is the current status of trial NCT02884791?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-02. Estimated completion is 2023-05-30.
What interventions are being tested in trial NCT02884791?
The interventions under investigation include: oral carbohydrate challenge (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02884791?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.